Results 1 -
8
of
8
for
LORLATINIB
- Lorlatinib is used to treat a certain type of non-small cell lung cancer (NSCLC). Lorlatinib is in a class of medications called kinase ... Lorlatinib comes as a tablet to take by mouth. Take with or without food once daily. Take ...
- Lung Cancer/Statistics and Research ... Lung Cancer ... National Cancer Institute ... From the National Institutes of Health ... Learn what's new in lung cancer research ...
- Lung Cancer/Treatments and Therapies ... Lung Cancer ... This page lists cancer drugs approved by the Food and Drug Administration (FDA) for lung cancer. The list ...
- LiverTox: Clinical and Research Information on Drug-Induced Liver Injury
(National Institute of Diabetes and Digestive and Kidney Diseases) (National Library of Medicine) LiverTox® provides regularly updated, unbiased and easily accessed information on the diagnosis, cause, frequency, clinical patterns and management of ... - Non-small cell lung cancer (NSCLC) treatment options include surgery, chemotherapy, radiation therapy, targeted therapy, and immunotherapy. Laser therapy, ...
- Non-small cell lung cancer (NSCLC) treatment options include surgery, chemotherapy, radiation therapy, targeted therapy, and immunotherapy. Laser therapy, ...
- Breastfeeding/Statistics and Research ... Breastfeeding ... National Library of Medicine ... From the National Institutes of Health ... The LactMed® database contains information ...
- Lung Cancer/Start Here ... Lung Cancer ... National Cancer Institute ... From the National Institutes of Health ... Non-small cell lung cancer (NSCLC) treatment options include ...
(National Cancer Institute) 